• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9-10 岁开始接种 HPV 疫苗与 13-17 岁青少年 HPV 疫苗接种及时率的相关性。2016-2020 年。

The association of initiating HPV vaccination at ages 9-10 years and up-to-date status among adolescents ages 13-17 years, 2016-2020.

机构信息

Surveillance & Health Equity Science Research Program, American Cancer Society, Atlanta, GA, USA.

Interventions & Implementation, American Cancer Society, Atlanta, GA, USA.

出版信息

Hum Vaccin Immunother. 2023 Dec 31;19(1):2175555. doi: 10.1080/21645515.2023.2175555. Epub 2023 Feb 7.

DOI:10.1080/21645515.2023.2175555
PMID:36748322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10026883/
Abstract

Recent guidelines from the American Cancer Society stress HPV vaccination series initiation at the youngest opportunity, i.e., age 9 years. There are limited data on the association between initiating HPV vaccination at ages 9-10 years and up-to-date (UTD) status. In this study, we compare nationally representative UTD HPV vaccination rates between adolescents who initiated the series younger (ages 9-10 years) vs. older (≥ age 11 years). Five years of pooled data (2016-2020) from National Immunization Survey-Teen were used to estimate the UTD HPV vaccination prevalence among younger vs. older initiating 13-17-year-olds. Adjusted logistic regression models estimated prevalence ratios (aPRs), differences (aDs), and difference in differences (aDDs) in prevalence of being UTD to assess the overall association of age at initiation with being UTD and differences in sociodemographic predictors of being UTD among younger vs. older initiators. UTD prevalence for younger initiators was 93% compared with 72% among older initiators (aPR: 1.27,95%CI: 1.24,1.31). Among older initiators, UTD prevalence was significantly different by sex, insurance status, and current age; no such differences were observed among younger initiators. Results indicate that younger initiation is associated with a 27% higher UTD prevalence, highlighting the importance of promoting younger initiation, particularly among those with health-care barriers.

摘要

最近,美国癌症协会的指南强调应在最早的机会,即 9 岁时开始 HPV 疫苗系列接种。关于在 9-10 岁时开始接种 HPV 疫苗与最新(UTD)状态之间的关联,数据有限。在这项研究中,我们比较了在较年轻(9-10 岁)和较年长(≥11 岁)时开始接种系列疫苗的青少年中,全国代表性的 UTD HPV 疫苗接种率。使用来自国家免疫调查-青少年的 5 年(2016-2020 年)合并数据,来估计年轻(9-10 岁)和年长(≥11 岁)启动者中 13-17 岁青少年的 UTD HPV 疫苗接种流行率。调整后的逻辑回归模型估计了 UTD 流行率的比值比(aPR)、差异(aD)和差异差异(aDD),以评估年龄开始与 UTD 的总体关联,以及年轻和年长启动者之间 UTD 的社会人口预测因素的差异。年轻启动者的 UTD 流行率为 93%,而年长启动者为 72%(aPR:1.27,95%CI:1.24,1.31)。在年长启动者中,UTD 流行率在性别、保险状况和当前年龄方面存在显著差异;而在年轻启动者中则没有观察到这种差异。结果表明,年轻启动与 UTD 流行率提高 27%相关,这突出了促进年轻启动的重要性,尤其是在那些存在医疗保健障碍的人群中。

相似文献

1
The association of initiating HPV vaccination at ages 9-10 years and up-to-date status among adolescents ages 13-17 years, 2016-2020.9-10 岁开始接种 HPV 疫苗与 13-17 岁青少年 HPV 疫苗接种及时率的相关性。2016-2020 年。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2175555. doi: 10.1080/21645515.2023.2175555. Epub 2023 Feb 7.
2
Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series.人乳头瘤病毒疫苗开始接种时的年龄对种族/族裔与疫苗系列接种完成情况之间关联的影响。
Vaccine. 2024 Apr 19;42(11):2827-2836. doi: 10.1016/j.vaccine.2024.03.050. Epub 2024 Mar 21.
3
Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.HPV 疫苗接种年龄的描述性流行病学:利用 2020 年 NIS-Teen 的分析。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2204784. doi: 10.1080/21645515.2023.2204784.
4
Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.HPV 疫苗接种启动和完成情况的趋势:2008-2018 年,9-12 岁年龄组。
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-012765. Epub 2021 May 3.
5
County-Level Factors Associated With HPV Vaccine Coverage Among 11-Year-Olds to 12-Year-Olds Living in Florida in 2019.2019 年,居住在佛罗里达州的 11 至 12 岁儿童 HPV 疫苗接种率与县级因素相关。
J Adolesc Health. 2023 Jan;72(1):130-137. doi: 10.1016/j.jadohealth.2022.09.005. Epub 2022 Oct 13.
6
Human papillomavirus vaccinations at recommended ages: How a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley.推荐年龄的人乳头瘤病毒疫苗接种:基于中学的教育和疫苗接种计划如何提高里奥格兰德河谷的接种率。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2133315. doi: 10.1080/21645515.2022.2133315. Epub 2022 Oct 17.
7
Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings.基于 CBPR 方法提高 HPV 疫苗接种率对减少年轻同胞间免疫接种差异的辅助作用。
J Community Health. 2019 Jun;44(3):544-551. doi: 10.1007/s10900-018-00610-9.
8
Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.影响密西西比州医疗补助计划中人类乳头瘤病毒(HPV)疫苗系列接种完成的因素。
Vaccine. 2020 Feb 18;38(8):2051-2057. doi: 10.1016/j.vaccine.2019.12.030. Epub 2020 Jan 21.
9
Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017.按都会统计区划分的美国青少年中 HPV 疫苗未接种率相关因素,全国免疫调查-青少年,2016-2017 年。
Hum Vaccin Immunother. 2020 Mar 3;16(3):562-572. doi: 10.1080/21645515.2019.1670036. Epub 2019 Oct 25.
10
Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.美国农村和偏远地区HPV疫苗使用增加的相关因素。
Public Health Nurs. 2016 Jul;33(4):283-94. doi: 10.1111/phn.12223. Epub 2015 Aug 31.

引用本文的文献

1
Using immunization registry data to explore initiation of HPV vaccination at ages 9 and 10.利用免疫接种登记数据探索9至10岁人群人乳头瘤病毒疫苗接种起始情况。
Hum Vaccin Immunother. 2025 Dec;21(1):2547432. doi: 10.1080/21645515.2025.2547432. Epub 2025 Aug 17.
2
How Immunization Information Systems Inform Age-Based HPV Vaccination Recommendations in the United States: A Mixed-Methods Study.免疫接种信息系统如何为美国基于年龄的人乳头瘤病毒疫苗接种建议提供信息:一项混合方法研究
Vaccines (Basel). 2025 Jun 30;13(7):716. doi: 10.3390/vaccines13070716.
3
Human papillomavirus vaccine administration opportunities at well visits in adolescents.青少年定期体检时的人乳头瘤病毒疫苗接种时机
BMC Public Health. 2025 Jun 4;25(1):2084. doi: 10.1186/s12889-025-23235-9.
4
Human papillomavirus vaccination at age 9 or 10 years to increase coverage - a narrative review of the literature, United States 2014-2024.9至10岁接种人乳头瘤病毒疫苗以提高覆盖率——美国2014 - 2024年文献综述
Hum Vaccin Immunother. 2025 Dec;21(1):2480870. doi: 10.1080/21645515.2025.2480870. Epub 2025 Apr 14.
5
A Cross-Sectional Analysis of 2017-2022 National Immunization Survey: Sociodemographic Disparities Associated With Human Papillomavirus Vaccine Initiation and Completion Series Among US Adolescents.2017-2022 年全国免疫调查的横断面分析:美国青少年中 HPV 疫苗接种启动和完成系列与社会人口统计学差异相关。
Cancer Control. 2024 Jan-Dec;31:10732748241293674. doi: 10.1177/10732748241293674.
6
Assessing the long-term implications of age 9 initiation of HPV vaccination on series completion by age 13-15 in the US: projections from an age-structured vaccination model.评估美国9岁开始接种人乳头瘤病毒(HPV)疫苗对13至15岁完成全程接种的长期影响:基于年龄结构接种模型的预测
Front Pediatr. 2024 Jun 27;12:1393897. doi: 10.3389/fped.2024.1393897. eCollection 2024.
7
HPV vaccine standing orders and communication in primary care: A qualitative study.HPV 疫苗常规接种和初级保健中的沟通:一项定性研究。
Vaccine. 2024 Jul 25;42(19):3981-3988. doi: 10.1016/j.vaccine.2024.05.008. Epub 2024 May 29.
8
Age nine is possible: Improving age 9 HPV initiation through a national quality improvement initiative during the COVID-19 pandemic.九岁即可接种:在 COVID-19 大流行期间通过国家质量改进倡议提高九岁人群 HPV 疫苗接种率。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2284359. doi: 10.1080/21645515.2023.2284359. Epub 2023 Nov 22.
9
Mothers' perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds.母亲对 9-10 岁儿童 HPV 疫苗接种启动的看法和态度。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2270842. doi: 10.1080/21645515.2023.2270842. Epub 2023 Nov 13.
10
Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview.支持9岁开始接种人乳头瘤病毒(HPV)疫苗的证据:收集概述。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2269026. doi: 10.1080/21645515.2023.2269026. Epub 2023 Oct 12.

本文引用的文献

1
Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9.为什么美国儿科学会建议在 9 岁时开始接种 HPV 疫苗。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2146434. doi: 10.1080/21645515.2022.2146434. Epub 2022 Nov 20.
2
Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.美国医疗保健可及性和利用率以及人乳头瘤病毒 (HPV) 疫苗接种启动方面的差异。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5390-5396. doi: 10.1080/21645515.2021.1989919. Epub 2021 Nov 4.
3
Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.HPV 疫苗接种启动和完成情况的趋势:2008-2018 年,9-12 岁年龄组。
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-012765. Epub 2021 May 3.
4
Trends in Human Papillomavirus Vaccination in Commercially Insured Children in the United States.美国商业保险儿童中人类乳头瘤病毒疫苗接种趋势。
Pediatrics. 2020 Oct;146(4). doi: 10.1542/peds.2019-3557. Epub 2020 Sep 14.
5
Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey.美国父母接种人乳头瘤病毒疫苗系列的意愿:一项全国性的横断面调查。
Lancet Public Health. 2020 Sep;5(9):e484-e492. doi: 10.1016/S2468-2667(20)30139-0. Epub 2020 Jul 21.
6
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation.人乳头瘤病毒疫苗接种 2020 指南更新:美国癌症协会指南改编。
CA Cancer J Clin. 2020 Jul;70(4):274-280. doi: 10.3322/caac.21616. Epub 2020 Jul 8.
7
Provider Experience Recommending HPV Vaccination Before Age 11 Years.医务人员推荐 HPV 疫苗接种年龄提前至 11 岁。
J Pediatr. 2020 Feb;217:92-97. doi: 10.1016/j.jpeds.2019.10.025. Epub 2019 Nov 19.
8
Human Papillomavirus-Attributable Cancers - United States, 2012-2016.人乳头瘤病毒相关癌症 - 美国,2012-2016 年。
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):724-728. doi: 10.15585/mmwr.mm6833a3.
9
Quality Improvement Initiative to Improve Human Papillomavirus Vaccine Initiation at 9 Years of Age.提高人乳头瘤病毒疫苗在 9 岁时接种率的质量改进措施。
Acad Pediatr. 2018 Sep-Oct;18(7):769-775. doi: 10.1016/j.acap.2018.05.005. Epub 2018 May 26.
10
Association of physicians perceived barriers with human papillomavirus vaccination initiation.医生感知障碍与人乳头瘤病毒疫苗接种启动的关联。
Prev Med. 2017 Dec;105:219-225. doi: 10.1016/j.ypmed.2017.07.016. Epub 2017 Aug 20.